Skip to content

Cognitive Rehabilitation for PD

Cognitive Rehabilitation for Individuals With Parkinson's Disease and MCI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03335150
Acronym
CogSMART-PD
Enrollment
110
Registered
2017-11-07
Start date
2015-11-02
Completion date
2021-01-31
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease, Rehabilitation, Cognition

Brief summary

To investigate the effectiveness of a novel compensatory cognitive rehabilitation program for individuals with Parkinson's disease (PD) and mild cognitive impairment (MCI).

Detailed description

Eligible study participants will be randomly assigned to one of two interventions: 1) Cognitive Rehabilitation (Cognitive Symptom Management and Rehabilitation Therapy for Parkinson's disease; CogSMART-PD) or 2) Supportive Care. Interventions are held within a group format consisting of approximately 5 individuals with PD. Groups will meet once per week for 1.5 hours over a 10-week period. Neuropsychological testing will be administered pre- and post-intervention as well as 6- and 12-months after the intervention.

Interventions

BEHAVIORALCogSMART-PD

Cognitive Rehabilitation for persons with PD-MCI

BEHAVIORALSupportive Care

Support Group for persons with PD-MCI

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Investigator and Assessor are blinded to group assignment.

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of Parkinson's disease 2. Mild Cognitive Impairment 3. Over 40 years of age 4. Fluent English speaker

Exclusion criteria

Other neurological conditions (e.g., stroke) besides Parkinson's disease

Design outcomes

Primary

MeasureTime frameDescription
Wechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled ScoreBaseline and Week 10The WAIS-IV Matrix Reasoning test is a validated, objective measure of executive function. Scaled scores range from 0 to 26. Higher scores indicate better executive function. Scores reported below are change scores.

Secondary

MeasureTime frameDescription
Informant Questionnaire on Cognitive Decline in the Elderly-Self Report (IQCODE-SR) Total ScoreBaseline and Week 10The measure examines self-reported change in cognition over time. Scores range from 16 - 80, with higher scores indicating worse functioning (or more cognitive decline). Scores reported below are change scores.
Cognitive Problems and Strategies Assessment (CPSA) Memory Strategies Use ScoreBaseline and Week 10CPSA measures cognitive problems and memory strategy use. The range for scores is 0 - 90, with higher scores indicating higher frequency of using memory and thinking strategies. Scores reported below are change scores.
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) Total ScoreBaseline and Week 10IQCODE is a self-report questionnaire for caregivers that measures possible dementia and cognitive decline of the patient. The range for scores is 26 - 130, with higher score representing worse functioning/higher cognitive decline in the patient. Scores reported below are change scores.
Delis-Kaplan Executive Functioning System (D-KEFS): 20 Questions Test Total Questions Asked Scaled ScoreBaseline and Week 10D-KEFS: 20 Questions Test measures executive function. The range of scores is 1 - 19 with a higher score representing better executive function. Scores reported below are change scores.
World Health Organization Quality of Life (WHOQOL)-BREF Psychological Domain Transformed ScoreBaseline and Week 10WHOQOL-BREF is a self-reported measure of quality of life. Transformed score for the psychological domain ranges from 0 to 100. Higher scores indicate better quality of life. Scores reported below are change scores.
Parkinson's Disease Questionnaire-39 (PDQ-39) Total ScoreBaseline and Week 10The PDQ-39 is a patient-reported measure of health and quality life over a 1-month period in individuals with Parkinson's disease. Total scores range from 0 to 156. Higher scores indicate poorer quality of life. Scores reported below are change scores.
Neuropsychiatric Inventory-Questionnaire (NPI-Q) Total Month ScoreBaseline and Week 10The NPI-Q is a self-reported measure of neuropsychiatric symptoms over a 1 month period and 1 year period. Total month scores range from 0 to 156. Higher scores indicate greater severity of neuropsychiatric symptoms. Scores reported below are change scores.
Memory for Intention Test (MIST) Total ScoreBaseline and Week 10MIST measures prospective memory. The range for scores is 0 - 48 with a higher score representing better prospective memory. Scores reported below are change score.

Countries

United States

Participant flow

Participants by arm

ArmCount
Supportive Care
Support Group for PD Supportive Care: Support Group for persons with PD
54
CogSMART-PD
Cognitive Rehabilitation for PD CogSMART-PD: Cognitive Rehabilitation for persons with PD
55
Total109

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event01
Overall StudyWithdrawal by Subject104

Baseline characteristics

CharacteristicTotalSupportive CareCogSMART-PD
Age, Continuous69.39 years
STANDARD_DEVIATION 7.6
70.59 years
STANDARD_DEVIATION 7.06
68.22 years
STANDARD_DEVIATION 7.98
Baseline Medication725.09 milligrams
STANDARD_DEVIATION 464.46
685.26 milligrams
STANDARD_DEVIATION 445.71
764.17 milligrams
STANDARD_DEVIATION 483.1
Cognitive Status
Mild Cognitive Impairment
85 Participants40 Participants45 Participants
Cognitive Status
Normal Cognition
23 Participants14 Participants9 Participants
Duration of Disease71.18 months
STANDARD_DEVIATION 50.68
69.02 months
STANDARD_DEVIATION 55.97
73.27 months
STANDARD_DEVIATION 45.43
Education15.97 years
STANDARD_DEVIATION 2.34
16.15 years
STANDARD_DEVIATION 2.41
15.8 years
STANDARD_DEVIATION 2.29
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants4 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
102 Participants50 Participants52 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Motor Symptoms12.01 seconds
STANDARD_DEVIATION 4.3
12.28 seconds
STANDARD_DEVIATION 4.85
11.76 seconds
STANDARD_DEVIATION 3.73
Race/Ethnicity, Customized
Race
American Indian or Alaskan Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race
Asian
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Race
Black or African American
3 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Race
Hispanic or Latino
5 Participants2 Participants3 Participants
Race/Ethnicity, Customized
Race
Native Hawaiian or Pacific Islander
2 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Race
White or Caucasian
98 Participants49 Participants49 Participants
Sex: Female, Male
Female
32 Participants20 Participants12 Participants
Sex: Female, Male
Male
77 Participants34 Participants43 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 550 / 55
other
Total, other adverse events
0 / 550 / 55
serious
Total, serious adverse events
0 / 551 / 55

Outcome results

Primary

Wechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score

The WAIS-IV Matrix Reasoning test is a validated, objective measure of executive function. Scaled scores range from 0 to 26. Higher scores indicate better executive function. Scores reported below are change scores.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started and 2 dropped during group. Therefore, 50 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareWechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score0.22 score on a scaleStandard Deviation 2.35
CogSMART-PDWechsler Adult Intelligence Scale-IV (WAIS-IV) Matrix Reasoning Test Total Scaled Score0.42 score on a scaleStandard Deviation 2.43
p-value: 0.6662Mixed Models Analysis
p-value: 0.1617Mixed Models Analysis
p-value: 0.6236Mixed Models Analysis
Secondary

Cognitive Problems and Strategies Assessment (CPSA) Memory Strategies Use Score

CPSA measures cognitive problems and memory strategy use. The range for scores is 0 - 90, with higher scores indicating higher frequency of using memory and thinking strategies. Scores reported below are change scores.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, and 2 were missing info. Therefore, 48 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareCognitive Problems and Strategies Assessment (CPSA) Memory Strategies Use Score-0.24 score on a scaleStandard Deviation 11.16
CogSMART-PDCognitive Problems and Strategies Assessment (CPSA) Memory Strategies Use Score10.17 score on a scaleStandard Deviation 16.96
p-value: 0.001Mixed Models Analysis
Secondary

Delis-Kaplan Executive Functioning System (D-KEFS): 20 Questions Test Total Questions Asked Scaled Score

D-KEFS: 20 Questions Test measures executive function. The range of scores is 1 - 19 with a higher score representing better executive function. Scores reported below are change scores.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started and 2 dropped during group. Therefore, 50 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareDelis-Kaplan Executive Functioning System (D-KEFS): 20 Questions Test Total Questions Asked Scaled Score-0.09 score on a scaleStandard Deviation 2.7
CogSMART-PDDelis-Kaplan Executive Functioning System (D-KEFS): 20 Questions Test Total Questions Asked Scaled Score1.06 score on a scaleStandard Deviation 3.15
p-value: 0.0496Mixed Models Analysis
Secondary

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) Total Score

IQCODE is a self-report questionnaire for caregivers that measures possible dementia and cognitive decline of the patient. The range for scores is 26 - 130, with higher score representing worse functioning/higher cognitive decline in the patient. Scores reported below are change scores.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group, 5 declined a caregiver, and 1 was missing info. 39 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, 2 were missing info, and 4 declined a caregiver. 44 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) Total Score-4.49 score on a scaleStandard Deviation 7.03
CogSMART-PDInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) Total Score-10.46 score on a scaleStandard Deviation 12.55
p-value: 0.02Mixed Models Analysis
Secondary

Informant Questionnaire on Cognitive Decline in the Elderly-Self Report (IQCODE-SR) Total Score

The measure examines self-reported change in cognition over time. Scores range from 16 - 80, with higher scores indicating worse functioning (or more cognitive decline). Scores reported below are change scores.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, and 1 was missing info. Therefore, 49 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareInformant Questionnaire on Cognitive Decline in the Elderly-Self Report (IQCODE-SR) Total Score-5.51 score on a scaleStandard Deviation 7.84
CogSMART-PDInformant Questionnaire on Cognitive Decline in the Elderly-Self Report (IQCODE-SR) Total Score-8.86 score on a scaleStandard Deviation 8.19
p-value: 0.047Mixed Models Analysis
Secondary

Memory for Intention Test (MIST) Total Score

MIST measures prospective memory. The range for scores is 0 - 48 with a higher score representing better prospective memory. Scores reported below are change score.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started and 2 dropped during group. Therefore, 50 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareMemory for Intention Test (MIST) Total Score4 score on a scaleStandard Deviation 5.43
CogSMART-PDMemory for Intention Test (MIST) Total Score2.82 score on a scaleStandard Deviation 6.87
p-value: 0.444Mixed Models Analysis
p-value: 0.0233Mixed Models Analysis
p-value: <0Mixed Models Analysis
Secondary

Neuropsychiatric Inventory-Questionnaire (NPI-Q) Total Month Score

The NPI-Q is a self-reported measure of neuropsychiatric symptoms over a 1 month period and 1 year period. Total month scores range from 0 to 156. Higher scores indicate greater severity of neuropsychiatric symptoms. Scores reported below are change scores.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group, 5 declined a caregiver, and 2 were missing info. 38 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, 3 were missing info, and 4 declined a caregiver. 43 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareNeuropsychiatric Inventory-Questionnaire (NPI-Q) Total Month Score1.82 score on a scaleStandard Deviation 6.63
CogSMART-PDNeuropsychiatric Inventory-Questionnaire (NPI-Q) Total Month Score-2.30 score on a scaleStandard Deviation 9.15
p-value: 0.0263Mixed Models Analysis
Secondary

Parkinson's Disease Questionnaire-39 (PDQ-39) Total Score

The PDQ-39 is a patient-reported measure of health and quality life over a 1-month period in individuals with Parkinson's disease. Total scores range from 0 to 156. Higher scores indicate poorer quality of life. Scores reported below are change scores.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, and 1 was missing info. Therefore, 49 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareParkinson's Disease Questionnaire-39 (PDQ-39) Total Score-2.31 score on a scaleStandard Deviation 11.56
CogSMART-PDParkinson's Disease Questionnaire-39 (PDQ-39) Total Score-2.69 score on a scaleStandard Deviation 10.27
p-value: 0.82Mixed Models Analysis
p-value: 0.0257Mixed Models Analysis
p-value: 0.1101Mixed Models Analysis
Secondary

World Health Organization Quality of Life (WHOQOL)-BREF Psychological Domain Transformed Score

WHOQOL-BREF is a self-reported measure of quality of life. Transformed score for the psychological domain ranges from 0 to 100. Higher scores indicate better quality of life. Scores reported below are change scores.

Time frame: Baseline and Week 10

Population: 54 enrolled in Supportive Care: 6 dropped before group started, 1 dropped before baseline, 2 dropped during group. Therefore, 45 completed measure. 55 were enrolled in CogSMART-PD: 3 dropped before group started, 2 dropped during group, and 1 was missing info. Therefore, 49 completed measure.

ArmMeasureValue (MEAN)Dispersion
Supportive CareWorld Health Organization Quality of Life (WHOQOL)-BREF Psychological Domain Transformed Score4.02 score on a scaleStandard Deviation 11.6
CogSMART-PDWorld Health Organization Quality of Life (WHOQOL)-BREF Psychological Domain Transformed Score0.04 score on a scaleStandard Deviation 9.85
p-value: 0.073Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026